X-linked inhibitor of apoptosis protein - a critical death resistance regulator and therapeutic target for personalized cancer therapy.
about
The Janus Face of Death Receptor Signaling during Tumor ImmunoeditingProtein transduction therapy into cochleae via the round window niche in guinea pigs.Mechanisms of sensorineural cell damage, death and survival in the cochlea.Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents.Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.Synergistic effect of allyl isothiocyanate (AITC) on cisplatin efficacy in vitro and in vivo.The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis.Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing SarcomaHypoxia promotes chemoresistance in acute lymphoblastic leukemia cell lines by modulating death signaling pathwaysTGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cellsWAP four-disulfide core domain protein 2 gene(WFDC2) is a target of estrogen in ovarian cancer cellsSurvivin and XIAP: two valuable biomarkers in medullary thyroid carcinomaInhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agentsLoss of XIAP facilitates switch to TNFα-induced necroptosis in mouse neutrophils.Resistance to Cell Death and Its Modulation in Cancer Stem Cells.X-linked inhibitor of apoptosis inhibits apoptosis and preserves the blood-brain barrier after experimental subarachnoid hemorrhage.X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.Small molecule inhibitor of apoptosis proteins antagonists: a patent review.Down-regulation of XIAP enhances the radiosensitivity of esophageal cancer cells in vivo and in vitro.The SMAC mimetic BV6 induces cell death and sensitizes different cell lines to TNF-α and TRAIL-induced apoptosis.Interactome network analysis identifies multiple caspase-6 interactors involved in the pathogenesis of HD.SL4, a chalcone-based compound, induces apoptosis in human cancer cells by activation of the ROS/MAPK signalling pathway.Sestrin2 facilitates death receptor-induced apoptosis in lung adenocarcinoma cells through regulation of XIAP degradation.Role of integrin-linked kinase in drug resistance of lung cancer.Dysregulation of TTP and HuR plays an important role in cancers.Pharmacological modulation of cell death in organ transplantation.Absence of RIPK3 predicts necroptosis resistance in malignant melanoma.Targeting of X-linked inhibitor of apoptosis protein and PI3-kinase/AKT signaling by embelin suppresses growth of leukemic cells.Survivin and XIAP - two potential biological targets in follicular thyroid carcinoma.The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells.Antitumoral effects of cyclin-dependent kinases inhibitors CR8 and MR4 on chronic myeloid leukemia cell linesDownregulation of X-linked inhibitor of apoptosis protein by '7-Benzylidenenaltrexone maleate' sensitizes pancreatic cancer cells to TRAIL-induced apoptosis."Scar-cinoma": viewing the fibrotic lung mesenchymal cell in the context of cancer biology.A General Strategy for Discovery of Inhibitors and Activators of RING and U-box E3 Ligases with Ubiquitin Variants.Targeting apoptosis in acute myeloid leukaemia.Cisplatin or LA-12 enhance killing effects of TRAIL in prostate cancer cells through Bid-dependent stimulation of mitochondrial apoptotic pathway but not caspase-10.Functional Genomics Approach Identifies Novel Signaling Regulators of TGFα Ectodomain Shedding.Overexpression of miR-489 enhances efficacy of 5-fluorouracil-based treatment in breast cancer stem cells by targeting XIAP.Modulation of ARTS and XIAP by Parkin Is Associated with Carnosic Acid Protects SH-SY5Y Cells against 6-Hydroxydopamine-Induced Apoptosis.
P2860
Q28070036-D00A9051-6778-4105-99BA-3FEE0E6F8709Q30375640-98C4BC23-7604-43BE-B05E-466DCF7E8074Q30412447-A4C18937-3183-4763-8315-1FB42C24E1EFQ33560133-5BCA225D-08E2-4DA8-8883-30DC5BAD78B2Q33841579-13F67526-5564-40D7-BB14-9AEB059BF943Q35980393-9B05A8A3-5EAE-4DE6-B99D-34774350A2A2Q36057163-8D3D91D2-2951-41CC-A986-FA6CE970AAF4Q36069954-32066235-D94B-425F-9707-E84239E13C1EQ36121582-E43505C0-EB84-4EAC-8F4B-53A76383B7F9Q36141609-7736DF38-C62C-4F6F-BD19-8E3F7F2A205BQ36348635-CFD08746-D198-4E54-95A6-1743E9C6EC16Q36629304-27E96BEA-55EF-4290-990C-F6B820D46898Q36750586-92B54E59-2BBC-4C28-AAFC-C4028A60C7E8Q37330876-3988BEC7-071C-42F0-94CB-C36E91ECB1B0Q37465889-3C3923B5-B878-47E8-AC9A-7BF4977E4674Q37708637-479F9229-5378-4F0F-AF8B-568246AB14CBQ37715016-64545E21-2153-4D27-A071-E57CB0BDC286Q38367445-6E848A19-35B3-4F30-A9A9-4EB666CE918FQ38484840-3268B08F-62DE-4B56-893E-C613428C4AD1Q38694603-4728C5ED-1945-4514-8AA3-7CA187271BE5Q38755349-22E83421-071F-46BA-86AD-540513F0FA63Q38791517-283D0EDC-FCDA-4B9F-92D8-485FE6C0A3BBQ38825003-54D59124-14A3-4EE4-AD21-A239EA47ABA2Q38840371-85C7C96E-9FC5-4A6D-AEB1-287CE68A9C26Q38855959-940ACAEC-8617-42D1-921E-A700A0D8C0D1Q38958552-46397A2D-E615-4D30-ADC0-DB7FBEB514A9Q39290025-C41F4CC4-AC14-45A0-85EA-6EB2F3579AEBQ40555960-9E4935B3-8695-4DE5-8B5C-5FC497D0A7EDQ41006595-542E9F6D-FB32-417E-AB8F-9A2569D5F18AQ41200870-64F6FA24-F3B5-4E9A-970E-5BB426320B4DQ41236409-0F872C9E-65AB-47B9-AA08-8D166E6EC491Q41724012-D6435C81-D519-49F1-94FF-4F7C672A4081Q42365258-B085383F-2F67-496D-86DE-10265E341089Q42594342-59412953-3106-4062-B599-0AFAB555273CQ42635927-2E63981F-E568-43F5-B69E-A730FDA05F78Q44489428-E583B6B7-330C-4627-B0CF-47E8B4DD979EQ47100889-AC28C274-6BB8-47CD-8346-7579E0767EB7Q47582263-0A7A6383-3661-49A3-8D42-843BAC11A4AEQ48523013-90ED1D9F-6540-49E3-B205-11EB161BA53AQ48824701-0D22DFAD-9215-438D-B370-1E183356904E
P2860
X-linked inhibitor of apoptosis protein - a critical death resistance regulator and therapeutic target for personalized cancer therapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
X-linked inhibitor of apoptosi ...... r personalized cancer therapy.
@en
type
label
X-linked inhibitor of apoptosi ...... r personalized cancer therapy.
@en
prefLabel
X-linked inhibitor of apoptosi ...... r personalized cancer therapy.
@en
P2860
P356
P1476
X-linked inhibitor of apoptosi ...... or personalized cancer therapy
@en
P2093
Petra Obexer
P2860
P356
10.3389/FONC.2014.00197
P577
2014-07-28T00:00:00Z